地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:18372041646
邮箱:sales@amyjet.com

艾美捷科技代理BioGenex品牌产品。
Biogenex位于美国旧金山,是抗原修复的发明者,是致力于研发生产准确、可靠、可重复性的高效检测方法的自动化和标准化的先驱。BioGenex拥有全面的免疫组化全自动处理系统,包括i1000抗原修复系统、i6000自动染色仪、iVISION数码成像分析系统等,具有检测诊断的高度一致性,为科研和临床诊治提供高质量的参考依据。Biogenx i 系列免疫组化全自动处理系统是使您的科研和临床病理诊断国际化的最佳途径。
BioGenex is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining. We develop, manufacture and market automated slide-based staining instruments and offer a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR.
BioGenex的主要产品包括:
(1)IHC
Automation
Primary Antibodies
Antigen Retrieval & Dewax
Detection Systems
Controls
Ancillaries
(2)ISH/CISH
Automation
ISH/CISH Probes
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
(3)FISH
eFISH Automation
eFISH Probes
Nucleic Retrieval & Dewax
eFISH Visualization Kits
eFISH Ancillaries
(4)miRNA
miRNA Automation
miRNA Probes & Controls
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
(5)Multiplexing & Double Staining
Automation
Antibody Cocktails
Multiplexing
Antigen Retrieval & Dewax
Detection Systems
Ancillaries
(6)Special Stains
Automation
Special Stains
Ancillaries
(7)In Situ PCR
(8)1IF
" data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理BioGenex品牌产品"> 艾美捷科技代理BioGenex品牌产品
艾美捷科技代理Serumwerk Bernburg AG品牌。
Serumwerk Bernburg AG在医药产品、医疗器械和活性药物成分的开发和生产领域,已逾60多年。Serumwerk Bernburg AG为广大科研和临床工作者提供一系列碘化物的密度梯度分离液包括:即用型、多功能型分离液。该系列产品不仅可以分离多种种属如人、灵长类、啮齿类、兔、反刍动物等来源的多种细胞、亚细胞器,而且可以分离纯化膜囊泡、病毒、蛋白质、核酸以及脂蛋白等物质。公司的产品符合美国FDA及获得欧洲cGMP标准,它们具有安全无毒、低渗透性和分离纯化效果好等特点。

艾美捷科技代理Badrilla 品牌。
Badrilla公司拥有一支由经验丰富的科学家和工程师组成的研发团队,他们在心血管研究领域具有深厚的专业知识和丰富的实践经验,特别是蛋白质S-棕榈酰化在疾病中的作用,并确保在您的实验系统中准确、精确和可靠地测量生物标志物浓度。Badrilla公司的主要产品包括用于心血管研究的各种高质量试剂和工具。这些产品旨在帮助研究人员深入了解心血管系统的生理和病理过程,从而推动心血管疾病的治疗和预防。
具体来说,Badrilla公司的产品和服务可能涵盖以下几个方面:
(1)蛋白质研究工具:提供高质量的蛋白质试剂,帮助研究人员研究蛋白质的结构和功能,以及蛋白质在心血管疾病中的作用。
(2)心血管研究试剂:包括用于研究心肌兴奋-收缩耦联、心律失常、心肌肥大和心脏衰竭等心血管疾病的试剂。
(3)定制服务:根据研究人员的具体需求,提供定制化的试剂和服务,以满足其独特的研究需求。
<<< " data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Badrilla品牌"> 艾美捷科技代理Badrilla品牌

艾美捷科技代理Revmab Bioscience品牌。
Revmab Bioscience是一家专注于单克隆抗体药物研发和生产的生物技术公司。公司致力于通过创新的生物技术手段,开发高效、安全的抗体药物,用于治疗自身免疫疾病和感染性疾病。Revmab Bioscience采用高效表达系统,确保抗体的高产量和高纯度;拥有先进的生产工艺和质量控制体系,确保产品的稳定性和一致性;同时具备创新研发能,能够快速开发新型抗体药物。
Revmab公司可提供的产品包括:
(1)单克隆抗体药物:提供多种单克隆抗体药物,用于癌症、自身免疫疾病和感染性疾病的治疗。
(2)生物类似药:开发和生产的生物类似药,用于多种疾病的治疗。
(3)抗体药物偶联物(ADC):提供抗体药物偶联物,用于靶向治疗癌症。
(4)定制抗体开发:根据客户需求,提供定制化的抗体开发服务。
<<< " data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Revmab Bioscience品牌"> 艾美捷科技代理Revmab Bioscience品牌

Salimetrics是一家全球著名的唾液生物学研究领域专业产品供应商,其在唾液的收集方法、生物学性质及其(唾液中各生物组分的含量)定量检测技术拥有绝对的研发与产品供应优势。作为唾液生物学研究及诊断试剂盒应用领域的行业标准,其供应的唾液手机方案及唾液成分的ELISA检测试剂盒均专门唾液的理化性质所设计,可确保客户在科学研究或临床诊断中得到稳定、准确的唾液生物学信息,并同时具有操作简便、结果精确可靠、可重复性高、耗时少等诸多优点。Salimetrics的唾液检测实验室及拥有丰富的唾液生物学研发经验的专业团队可以为广大客户提供唾液生物学研究及诊断应用的专业指导。
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
产品名称 | 产品编号 | 产品参数 |
Salivary 17 Alpha-OHP ELISA Kit | 1-2602 | Catalog#: 1-2602 |
Salivary Alpha-Amylase Enzymatic Kit | 1-1902 | Catalog#:1-1902 |
Salivary Androstenedione ELISA Kit | 1-2902 | Catalog#:1-2902 |
Salivary C-Reactive Protein ELISA Kit | 1-2102 | Catalog#:1-2102 |
Salivary Cortisol ELISA Kit | 1-3002 | Catalog#:1-3002 |
Salivary Cotinine ELISA Kit | 1-2002 | Catalog#:1-2002 |
Salivary DHEA ELISA Kit | 1-1202 | Catalog#:1-1202 |
Salivary DHEA-S ELISA Kit | 1-1252 | Catalog#:1-1252 |
Salivary Estradiol ELISA Kit | 1-3702 | Catalog#:1-3702 |
Salivary Estriol ELISA Kit | 1-1802 | Catalog#:1-1802 |
HS Salivary Estriol ELISA Kit | 1-1802 | Catalog#:1-1802 |
Salivary Estrone ELISA Kit | 1-3202 | Catalog#:1-3202 |
Salivary Interleukin-1 Beta ELISA Kit | 1-3902 | Catalog#:1-3902 |
Salivary Interleukin-6 ELISA Kit | 1-3602 | Catalog#: 1-3602 |
Salivary Melatonin ELISA Kit | 1-3402 | Catalog#:1-3402 |
Salivary Progesterone ELISA Kit | 1-1502 | Catalog#:1-1502 |
Salivary Secretory IgA ELISA Kit | 1-1602 | Catalog#:1-1602 |
Salivary Testosterone ELISA Kit | 1-2402 | Catalog#:1-2402 |
Salivary Transferrin/Blood Contamination ELISA Kit | 1-1302 | Catalog#:1-1302 |
Salivary Uric Acid Assay Kit | 1-3802 | Catalog#:1-3802 |
Diagnostic Salivary Cortisol ELISA Kit (FDA, CE Mark) | 1-3102 | Catalog#:1-3102 |
Diagnostic Salivary Cotinine ELISA Kit (FDA, CE Mark) | 1-2112 | Catalog#:1-2112 |
Diagnostic Salivary DHEA ELISA Kit (CE Mark) | 1-2212 | Catalog#:1-2212 |
Diagnostic Salivary Estradiol ELISA Kit (FDA, CE Mark) | 1-3702 | Catalog#:1-3702 |
Diagnostic Salivary Estriol ELISA Kit (CE Mark) | 1-2812 | Catalog#:1-2812 |
Diagnostic Salivary Progesterone ELISA Kit (FDA, CE Mark) | 1-2502 | Catalog#:1-2502 |
Diagnostic Testosterone ELISA Kit (CE Mark) | 1-2312 | Catalog#:1-2312 |

艾美捷科技代理Diaclone品牌检测试剂。
Diaclone是一家集酶联免疫试剂盒、流式抗体为一体的公司,在炎症、肿瘤、免疫学领域深耕多年;ELISA 试剂盒可对细胞因子、趋化因子、 生长因子进行有效检测。Diaclone的产品线主要包括:细胞因子和细胞黏附分子的抗体:这些抗体被广泛应用于酶联免疫检测试剂盒中,用于检测和量化细胞因子和细胞黏附分子的表达水平。酶联免疫试剂盒(ELISA):Diaclone提供多种规格和型号的ELISA试剂盒,用于检测各种生物样本中的特定抗原或抗体。这些试剂盒具有灵敏度高、特异性强、操作简便等特点。酶联免疫斑点检测试剂盒(ELISpot):ELISpot技术是一种用于检测细胞分泌特定蛋白质(如细胞因子)的灵敏方法。Diaclone的ELISpot试剂盒可用于研究细胞免疫应答,如T细胞活性等。
" data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Diaclone品牌检测试剂"> 艾美捷科技代理Diaclone品牌检测试剂
![]()
艾美捷科技代理Medix Biochemica品牌。
Medix Biochemica是重要的体外诊断原材料供应商,生产和供应高质量的抗体、抗原和其他关键的IVD原材料,涵盖免疫测定、临床化学和分子诊断等细分市场。Medix Biochemica拥有5000多种产品,可提供超过95%的最常见试剂,用于检测开发、生产和验证。Medix Biochemica提供高质量的单克隆抗体,也可以提供定制OEM服务,让抗体生产变得轻松。该工艺包括通过细胞系驯化、支原体检测、生产优化和验证进行评估和优化。
Medix Biochemica产品包括:
(1)抗体/抗原/酶:包含5000多种产品,涵盖300多种指标;
(2)MedixMDx:分子生物学应用原料;
(3)生物样本和生物材料。
< " data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Medix Biochemica品牌"> 艾美捷科技代理Medix Biochemica品牌
艾美捷科技代理Roboscreen 品牌。
Roboscreen Diagnostics公司,正式名称为ROBOSCREEN GmbH,是一家专注于研发和生产高质量诊断工具的公司,在qPCR应用开发、单克隆抗体的产生以及它们在免疫化学测试构建中的应用方面具有高水平的专业知识。
ROBOSCREEN GmbH提供的产品和服务涵盖了病毒病原体检测、核酸提取以及神经退行性疾病诊断等多个领域,具体包括:
(1)病毒性病原体诊断产品:针对肝炎C、B和DELTA等病毒的诊断测试,以及用于HSV1/2、CMV、EBV和VZV等疱疹病毒的检测和定量的RealLine Kits。
(2)核酸提取产品:提供高效的核酸提取解决方案,如Rapid INSTANT Virus RNA/DNA Kit - FX,该产品支持仅需35分钟的自动化核酸提取,适用于96个样本的批量处理。
(3)神经退行性疾病诊断产品:包括用于阿尔茨海默病、帕金森病、克雅氏病和疯牛病等的诊断工具,如酶联免疫吸附HTAU total ELISA等。
(4)此外,ROBOSCREEN GmbH还提供科学研究产品,用于在科学项目范围内识别和测量生物标志物。
ROBOSCREEN GmbH技术优势包括:
创新能力:ROBOSCREEN GmbH以其创新能力而著称,不断开发新的诊断工具和方法,以应对不断变化的疾病挑战。
高质量产品:公司的产品以其高灵敏度、高特异性和操作简便而受到认可,支持快速、准确的诊断,有助于提高疾病监测和治疗的效率。
质量控制:ROBOSCREEN GmbH的生产流程遵循严格的质量控制标准,确保产品的可靠性和一致性。

Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |
<艾美捷科技代理MicroFIT品牌全系列产品
MicroFIT是一家在生物/医疗领域具有显著影响力的企业,专注于基于模拟人体环境和组织的平台技术,致力于为生物医疗领域提供创新的产品和服务。公司以成为“基于Bio-Convergence技术的仿生平台领先企业”为目标,不断探索和研发,旨在成长为一家提供个性化医疗所需仿生平台的全球性公司。

▍MicroFIT产品线
● StemFIT 3D-Plastic系列
StemFIT 3D-Plastic系列产品采用PS(聚苯乙烯)材料设计,融合了多种实用功能,旨在使大规模3D细胞培养变得更加容易、高效和经济。能广泛应用于再生医学、精准医疗、疾病建模、发育生物学、毒物学、宿主-微生物组相互作用、药物发现和基因编辑等多个领域。
| 型号 | H389600P-6 孔 | H389600P-单人 |
| 材料 | 聚苯乙烯 | 聚苯乙烯 |
| 特征 | 大规模培养, 经济实惠,易于移液, 疏水性 | 大众培养, 经济实惠,易于移液, 疏水性 |
| 井数量 | 每个 2,334 | 389 个 |
| 井径 | 600 微米 | 600 微米 |
| 单元格数量 | ≥ 1.2 x 106 | ≥ 1.2 x 106 |
| 细胞接种培养基的体积 | 1 毫升 | 1 毫升 |
| 细胞培养基体积 | 3 ~ 8 毫升 | 3 毫升 |
| 包装 | 3 包/箱 | 20 个 EA/CS,40 个 EA/CS |
● StemFIT 3D®
StemFIT 3D®是一款创新性的三维细胞培养板,带有凹形微孔的微孔板,其核心原理在于利用这些微孔将孔内的细胞浓缩,进而培养细胞聚集体。使细胞能够在三维空间内相互作用,更好地模拟了体内细胞的生长环境。StemFIT 3D®在三个维度上形成细胞聚集体,允许细胞向各个方向生长并与周围环境相互作用,通过扩散和传递为细胞提供营养、氧气和药物,从而提供更接近生物体真实情况的仿生环境。
| 型号 | 井型 | 井数 | 井径 | 细胞数量 | 播种培养基体积 | 总培养基体积 |
| H1613200 | Hexagon | 1613 | 200 μm | ≥ 6.0 x 105 | 500 μl | 1 ml |
| H853400 | Hexagon | 853 | 400 μm | ≥ 1.2 x 106 | 1 ml | 1.5 ml |
| H389600L/H389600H | Hexagon | 389 | 600 μm | ≥ 1.2 x 106 | 1 ml | H389600L-1.3 ml;H389600H-1.7 ml |
| H449800 | Hexagon | 449 | 800 μm | ≥ 2.4 x 106 | 1 ml | 4 ml |
| H2951000 | Hexagon | 295 | 1000 μm | ≥ 2.4 x 106 | 2 ml | 4 ml |
| C100600 | Circle | 100 | 600 μm | ≥ 6.0 x 105 | 2 ml | 700 μl |
| C163000 | Circle | 16 | 3,000 μm | 2.5 x 105 / well | 20 μl / well | 5 ml |
| C253000 | Circle | 25 | 3,000 μm | 2.5 x 105 / well | 20 μl / well | 3 ml |
● NanoFIT 3D®系列
NanoFIT 3D®系列细胞培养板通过实现线或柱结构的均匀纳米图案来提供仿生界面。这种独特的纳米拓扑结构能够模拟细胞外环境,允许科研人员通过诱导细胞调整其形态和排列,从而更精准地控制和分析特定细胞的反应。它有可能基于纳米图案最大限度地维持和分化细胞,在体内提供类似于ECM(细胞外基质)的环境,使细胞的形态和功能更接近体内真实状态。能维持细胞干性与分化;调节特定细胞靶向;多样化培养形式并且拥有专利技术保障。
| Type | Pattern | Size | Cat. No. |
| Sheet (Polydimethylsiloxane) | Line | 250 nm | N-Line250S |
| Sheet (Polydimethylsiloxane) | Line | 400 nm | N-Line400S |
| Sheet (Polydimethylsiloxane) | Post | 250 nm | N-Post250S |
| Sheet (Polydimethylsiloxane) | Post | 400 nm | N-Post400S |
| Sheet (Polydimethylsiloxane) | Flat | 250 nm | N-Flat250S |
| Sheet (Polydimethylsiloxane) | Flat | 400 nm | N-Flat400S |
| Dish (Polystyrene) | Line | 400 nm | N-Line400P |
● 微珠芯片
微珠芯片是一种专为大规模生产微型珠子而设计的微流控装置。它采用先进的材料和工艺制造,旨在利用胶原蛋白、PEGDA、PLGA等多种水凝胶材料,实现高效、精准的大规模微粒生产。具有卓越的耐化学性;精密的珠子生产能力;材料坚固耐用且可重用。
● PDMS膜
PDMS膜,即聚二甲基硅氧烷膜,作为应用最为广泛的硅基有机聚合物之一,、PDMS膜具有柔软弹性,能够轻松实现大幅度的拉伸变形,且在拉伸过程中仍能保持较好的物理性能和稳定性;具备超薄膜的结构特点,厚度可以做到极薄,在保证基本功能的前提下,最大程度地减少材料的使用和空间的占用;拥有良好的透气性,它允许气体分子自由通过,在生物相容性应用中,能为细胞提供适宜的气体交换环境,促进细胞的生长和代谢;在微流体装置等应用里,也能保证气体的顺畅流通,维持系统的稳定运行;拥有优异的光学透明性,几乎不会对光线的传播产生干扰;对生物组织无毒无害,不会引发明显的免疫反应,可安全地应用于生物医学领域。
<| Material | Diameter | Thickness |
| PDMS | 50 mm / 1.97 inch | 10 μm |
| PDMS | 50 mm / 1.97 inch | 30 μm |
| PDMS | 50 mm / 1.97 inch | 50 μm |
● PDMS定位
PDMS(聚二甲基硅氧烷)作为一种硅基弹性体,拥有高光学透明度,能让研究人员清晰地观察芯片内发生的微观反应和现象;化学稳定性极佳,可在各种化学环境下保持性能稳定;出色的变形性使其能够适应不同的实验需求和操作条件;优异的生物相容性则为生物样本的研究提供了安全可靠的环境。PDMS片上实验室采用了世界领先的PDMS LOC(Lab - on - a - Chip)技术。这项技术实现了在微米尺度上构建具有卓越成型性的纳米·微结构,将复杂的实验室功能集成到一个小小的芯片之上。
● SU-8微型模具
SU-8微型模具是一种感光聚合物模具,专门用于芯片实验室的微图案铸造。它采用环氧树脂基负光刻胶SU-8作为主要材料,通过精密的光刻工艺在晶圆上制造出微图案。相较于其他模具材料,SU-8微型模具的生产速度更快。该模具的高度可高达1,000μm,能够满足制造具有较大高度微结构的需求。这种模具在微流控芯片、生物传感器、微机电系统(MEMS)等领域的生产制造中发挥着重要作用。
| 通道高度 | 晶圆尺寸 | 层 |
| 100 μm 以下 | 4英寸 | 1层 |
| 100 μm 以下 | 6英寸 | 1层 |
| 110 - 200 微米 | 4英寸 | 1层 |
| 110 - 200 微米 | 6英寸 | 1层 |
| 210 - 300 微米 | 4英寸 | 2 层 |
| 310 - 500 微米 | 4英寸 | 超过 2 层 |
| 510 - 800 微米 | 4英寸 | 超过 3 层 |
● 晶圆厂工艺
在半导体产业飞速发展的今天,高效、精准且可靠的制造服务至关重要。MicroFIT凭借其专业的技术和丰富的经验,提供一站式的半导体制造服务,采用分布式外包流程,为客户解决各种制造难题。包括以下服务:
● 光刻:将精心设计的图案精准转移到晶圆上,这是半导体制造的关键起始步骤,为后续的工艺奠定基础,确保图案的高精度和准确性。
● 镀膜:通过各种工艺使金属、聚合物等材料以薄膜形式均匀沉积在硅衬底上,为芯片提供必要的功能层和保护层,增强芯片的性能和稳定性。
● 蚀刻:精确去除必要电路图案外的其余部分,可选择干蚀刻或湿蚀刻方法,以实现对材料的精细加工,塑造出所需的微纳结构。
● 粘接:在半导体制造中,用于将芯片与基板牢固粘合;在微流控器件制造里,用于通道形成后的处理,确保器件各部分之间的可靠连接和密封性。
● 切割:把在半导体晶片加工中制造的器件在图案形成后分离成一定的尺寸,为后续的封装和测试等步骤做准备。
● CMP(化学机械抛光):通过化学和物理过程的结合,对晶圆或玻璃基板进行抛光压平,使表面达到极高的平整度,满足半导体器件制造的严格要求。
" data-original="http://bioauxilium.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MicroFIT品牌全系列产品"> 艾美捷科技代理MicroFIT品牌全系列产品地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:17754422825
邮箱:sales@amyjet.com
0.2075